Investor
Biofourmis has restructured its business to pursue its original focus on data-driven patient monitoring alongside its more recent interest in standalone and companion digital therapeutics.
The company's implanted product acts as a closed-loop system that monitors and responds to brain activity by automatically delivering stimulation prior to the start of a seizure.
The latest round was led by Felicis Ventures. As part of that deal, Sundeep Peechu, managing director at the VC firm, will sit on the PicnicHealth board.
The company said it has grown its business by 400% in the last three months alone.
A new report from PitchBook projects solid growth in the industry, but also notes challenges in exits.
InfiniteMD was designed to help patients get more information about their condition via virtual visits.
A frequent partner of biopharmas and the FDA, it has raised $94 million from investors since its commercial launch in 2015.
The raise reportedly brings the company's valuation into unicorn territory.
The deal joins each company's voice sample datasets to improve R&D, and helps Sonde collect more data across platforms.
Google's cloud division poured in $100 million in funding to the telehealth company, along with the deal.